article thumbnail

5 Trends Driving the Future Growth of Digital Health & MedTech

HIT Consultant

“Healthcare is at a crossroads, facing unprecedented pressure and disruption — including affordability challenges, shifting patient expectations, and an increasing deluge of health data,” said Tim Durst, a managing director at Accenture who leads the global medical technology sector in the company’s Life Sciences practice.

article thumbnail

The Role of Intellectual Property in the Biopharmaceutical Sector

Healthcare ECONOMIST

Of particular interest from the health economics side: To model the impact of a potential change in the current intellectual property regime, our study assesses what the impact of overriding intellectual property rights for 10% of drugs would be.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IoT and The Rise of the Machines in Healthcare

Health Populi

For this annual report, Ordr analyzed security risks across over 500 deployments in healthcare, life sciences, retail, and manufacturing sectors for the 12 months June 2020 through June 2021. What’s unclear is how public policy and regulation can/will meet this moment. How to protect vulnerable groups of people?

article thumbnail

Digital Health Tools Are Finding Business Models – IQVIA’s 2021 Read on the Health of Digital Health

Health Populi

Evidence supporting the use of digital health tools if growing, tracked in Digital Health Trends 2021: Innovation, Evidence, Regulation, and Adoption from IQVIA Institute for Human Data Science. In the Age of COVID, over 90,000 new health apps were released, as the supply of digital therapeutics and wearables grew in 2020.

article thumbnail

Our Homes Are Health Delivery Platforms – The New Home Health/Care at CES 2021

Health Populi

The heart has been a digital health focus at CES for several years as sensors got added to wristworn activity trackers and mobile apps married to medical technologies that were once only available for use in a doctor’s office or outpatient clinic. Heart health at home. The deal has not yet been approved by the U.S.